You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma
- Disease
- lymphoma
- Drug Name
- Fostamatinib Disodium
- Generic Name
- Fostamatinib
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- II
- Start Date
- Mar 5, 2009
- Study Name
- C-935788-017
- Study Id
- D4300C00024
- ClinicalTrials.gov ID
- NCT00798096
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
